Cargando…
Metabolite Profiling of Alzheimer's Disease Cerebrospinal Fluid
Alzheimer's disease (AD) is a neurodegenerative disorder characterized by progressive loss of cognitive functions. Today the diagnosis of AD relies on clinical evaluations and is only late in the disease. Biomarkers for early detection of the underlying neuropathological changes are still lacki...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3281064/ https://www.ncbi.nlm.nih.gov/pubmed/22359596 http://dx.doi.org/10.1371/journal.pone.0031501 |